How many 8-K filings has Oric Pharmaceuticals, Inc. filed?

Oric Pharmaceuticals, Inc. (ORIC) has 10 8-K (Current Event Report) filings on record, spanning Jan 2024 to Dec 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Oric Pharmaceuticals, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Oric Pharmaceuticals, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Oric Pharmaceuticals, Inc. (ORIC) — 8-K Filings

All 8-K filings from Oric Pharmaceuticals, Inc.. Browse 10 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (10)

Oric Pharmaceuticals Files 8-K — Dec 8, 2025 Risk: low
Oric Pharmaceuticals, Inc. filed an 8-K on December 8, 2025, reporting other events and financial statements/exhibits. The filing date for the report is Decembe
Oric Pharmaceuticals Files 8-K on Shareholder Vote Matters — Jun 13, 2025 Risk: low
Oric Pharmaceuticals, Inc. filed an 8-K on June 13, 2025, reporting on a submission of matters to a vote of security holders that occurred on June 11, 2025. The
Oric Pharmaceuticals Files 8-K with Key Agreements and Sales — May 28, 2025 Risk: medium
On May 23, 2025, Oric Pharmaceuticals, Inc. filed an 8-K report detailing several events. These include entering into a material definitive agreement, unregiste
Oric Pharma Reports Director Changes and Compensation Updates — Mar 14, 2025 Risk: medium
Oric Pharmaceuticals, Inc. announced on March 11, 2025, changes in its board of directors and executive compensation arrangements. Specifically, the company rep
Oric Pharmaceuticals Files 8-K — Feb 25, 2025 Risk: low
Oric Pharmaceuticals, Inc. filed an 8-K on February 25, 2025, reporting other events and financial statements. The filing does not contain specific details abou
Oric Pharmaceuticals Files 8-K — Jan 13, 2025 Risk: low
Oric Pharmaceuticals, Inc. filed an 8-K on January 13, 2025, to report information under Regulation FD and to file financial statements and exhibits. The filing
Oric Pharmaceuticals Reports on Shareholder Vote — Jun 14, 2024 Risk: low
Oric Pharmaceuticals, Inc. filed an 8-K on June 14, 2024, to report on matters submitted to a vote of its security holders on June 12, 2024. The filing does not
Oric Pharmaceuticals Appoints New CEO, CMO, COO — Mar 29, 2024 Risk: medium
Oric Pharmaceuticals, Inc. announced on March 26, 2024, changes in its board and executive team. Dr. Paul Hastings has been appointed as the new Chief Executive
ORIC Pharma Enters Material Agreement, Sells Unregistered Equity — Jan 22, 2024
Oric Pharmaceuticals, Inc. filed an 8-K on January 22, 2024, reporting an event on January 20, 2024, concerning an entry into a material definitive agreement an
ORIC Pharma Files 8-K on Operations & Financial Condition — Jan 9, 2024
Oric Pharmaceuticals, Inc. filed an 8-K on January 9, 2024, to report on its results of operations and financial condition, as well as to make a Regulation FD d

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX